BPCE
Bank Pictet & Cie (Europe) Portfolio holdings
AUM
$4.68B
This Quarter Return
+11.73%
1 Year Return
+16.47%
3 Year Return
+101.24%
5 Year Return
+155.05%
10 Year Return
+381.72%
AUM
$2.86B
AUM Growth
+$2.86B
(+15%)
Cap. Flow
+$110M
Cap. Flow
% of AUM
3.83%
Top 10 Holdings %
Top 10 Hldgs %
45.35%
Holding
183
New
10
Increased
86
Reduced
41
Closed
14
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
$64.9M |
| 2 |
Otis Worldwide
OTIS
|
$30.4M |
| 3 |
Exact Sciences
EXAS
|
$22.7M |
| 4 |
Nike
NKE
|
$19.1M |
| 5 |
Thermo Fisher Scientific
TMO
|
$17.6M |
Top Sells
| 1 |
Bright Horizons
BFAM
|
$34.3M |
| 2 |
Medtronic
MDT
|
$26.8M |
| 3 |
Abbott
ABT
|
$14.3M |
| 4 |
Boston Scientific
BSX
|
$13.3M |
| 5 |
Fidelity National Information Services
FIS
|
$13.3M |
Sector Composition
| 1 | Healthcare | 22.72% |
| 2 | Technology | 17.44% |
| 3 | Consumer Discretionary | 13.7% |
| 4 | Communication Services | 12.98% |
| 5 | Financials | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Bristol-Myers Squibb
BMY
$96B
| $1.26M | 0.04% | 18,902 -1,204 | -6% | -$80.4K |
|
102
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.8B
| $1.24M | 0.04% | 16,280 | – | – |
|
103
Ross Stores
ROST
$48.1B
| $1.15M | 0.04% | 9,291 +6,172 | +198% | +$765K |
|
104
Verizon
VZ
$186B
| $1.1M | 0.04% | 19,555 | – | – |
|
105
ICICI Bank
IBN
$113B
| $962K | 0.03% | 113,373 -62,937 | -36% | -$534K |
|
106
Guardant Health
GH
$8.41B
| $947K | 0.03% | 7,628 +1,941 | +34% | +$241K |
|
107
Palo Alto Networks
PANW
$127B
| $918K | 0.03% | 2,475 +398 | +19% | +$148K |
|
108
Intel
INTC
$107B
| $848K | 0.03% | 15,100 -5,000 | -25% | -$281K |
|
109
Stryker
SYK
$150B
| $815K | 0.03% | 3,137 +448 | +17% | +$116K |
|
110
Natera
NTRA
$23.1B
| $802K | 0.03% | 7,068 +1,041 | +17% | +$118K |
|
111
Gilead Sciences
GILD
$140B
| $794K | 0.03% | 11,525 | – | – |
|
112
Biogen
BIIB
$19.4B
| $786K | 0.03% | 2,269 -220 | -9% | -$76.2K |
|
113
Cisco
CSCO
$274B
| $779K | 0.03% | 14,706 | – | – |
|
114
Pfizer
PFE
$141B
| $755K | 0.03% | 19,291 +212 | +1% | +$8.3K |
|
115
10x Genomics
TXG
$1.74B
| $714K | 0.02% | 3,648 +1,556 | +74% | +$305K |
|
116
Moderna
MRNA
$9.37B
| $713K | 0.02% | 3,035 +215 | +8% | +$50.5K |
|
117
Ecolab
ECL
$78.6B
| $696K | 0.02% | 3,380 -1,423 | -30% | -$293K |
|
118
Canadian National Railway
CNI
$60.4B
| $690K | 0.02% | 6,530 | – | – |
|
119
Enbridge
ENB
$105B
| $689K | 0.02% | 17,200 | – | – |
|
120
Castle Biosciences
CSTL
$696M
| $688K | 0.02% | 9,386 +1,266 | +16% | +$92.8K |
|
121
TJX Companies
TJX
$152B
| $657K | 0.02% | 9,738 -440 | -4% | -$29.7K |
|
122
Globus Medical
GMED
$8.27B
| $638K | 0.02% | 8,226 -71,433 | -90% | -$5.54M |
|
123
Akamai
AKAM
$11.3B
| $633K | 0.02% | 5,432 +636 | +13% | +$74.1K |
|
124
Insulet
PODD
$23.9B
| $631K | 0.02% | 2,300 +981 | +74% | +$269K |
|
125
CRISPR Therapeutics
CRSP
$4.71B
| $628K | 0.02% | +3,877 | New | +$628K |
|